InvestorsHub Logo
Followers 54
Posts 1763
Boards Moderated 0
Alias Born 03/22/2015

Re: fabius post# 24

Thursday, 07/25/2019 11:22:32 AM

Thursday, July 25, 2019 11:22:32 AM

Post# of 169

Whatever happens Mr Odidi is always "pleased".

Can't he just say...we are disappointed once in a while.







I suspect he actually was very pleased about this.





This is probably good for IPCI. They could have been torn up at AdCom for most likely poor results on chewing HAL studies, with subsequent CRL crash. But now the application goes to purgatory. Instead of a two-time loser, they still have a potential asset in the form of a pending NDA, for who knows how long.





The FDA informed the Company that it would continue to review the Company’s NDA according to the existing Prescription Drug User Fee Act (“PDUFA”) timeline, but noted that, due to the postponement of the AADPAC meeting, it is possible that the FDA may be unable to meet the PDUFA goal date of August 28, 2019.









Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCIF News